3Aware

3Aware

AI-driven post-market surveillance platform for medical devices

About 3Aware

Simplify's Rating
Why 3Aware is rated
A
Rated A on Competitive Edge
Rated A on Growth Potential
Rated A on Differentiation

Industries

Data & Analytics

Healthcare

Company Size

11-50

Company Stage

Early VC

Total Funding

$2.2M

Headquarters

Indianapolis, Indiana

Founded

2022

Overview

3Aware.ai focuses on post-market surveillance (PMS) of medical devices, helping manufacturers comply with regulations like the EU Medical Device Regulation (MDR). Their main product, aiSurveillance, is a real-time software platform that combines three separate solutions into one, allowing for efficient access, analysis, and alerts for real-world clinical data. By using artificial intelligence, the platform automates data collection and analysis, which helps reduce the time and costs associated with compliance for medical device manufacturers. Unlike competitors, 3Aware.ai offers a customizable, subscription-based service that adapts to the specific needs of each client, ensuring ongoing support and updates. The company's goal is to enhance the safety and effectiveness of medical devices while streamlining the regulatory process for manufacturers.

📈
Significant Headcount Growth
Simplify Jobs

Simplify's Take

What believers are saying

  • The integration with Mayo Clinic enhances device coverage and automates post-market clinical follow-up.
  • 3Aware's aiSurveillance reduces compliance costs by 50% and time by 90%.
  • The appointment of Prashant Thumma as CTO strengthens 3Aware's technology leadership.

What critics are saying

  • Over-reliance on Mayo Clinic data may limit diversity and increase vulnerability.
  • New CTO Prashant Thumma's strategies might disrupt current operations or delay projects.
  • Raising $8 million in equity suggests potential cash flow challenges for 3Aware.

What makes 3Aware unique

  • 3Aware.ai integrates three solutions into one platform, enhancing efficiency in post-market surveillance.
  • The aiSurveillance platform automates data collection, reducing time and costs for MedTech companies.
  • 3Aware's collaboration with Mayo Clinic provides access to extensive, diverse clinical data.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$2.1M

Above

Industry Average

Funded Over

1 Rounds

Early VC funding comparison data is currently unavailable. We're working to provide this information soon!
Early VC Funding Comparison
Coming Soon

Benefits

Unlimited Paid Time Off

Remote Work Options

Flexible Work Hours

401(k) Company Match

Health Insurance

Vision Insurance

Dental Insurance

Life Insurance

Disability Insurance

Professional Development Budget

Stock Options

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

↑ 3%

1 year growth

↑ 0%

2 year growth

↑ 16%
PharmiWeb
Jul 30th, 2024
3Aware Welcomes Prashant Thumma As First Chief Technology Officer

INDIANAPOLIS, ID / ACCESSWIRE / July 30, 2024 / 3Aware, a leader in real-time surveillance and data solutions for medical technology, is pleased to announce the appointment of Prashant Thumma as its first Chief Technology Officer (CTO). Mr. Thumma brings a wealth of experience in technology leadership and innovation, poised to drive 3Aware's strategic growth.Thumma joins 3Aware with a distinguished career in health information technology. In his most recent role as Platform Architecture Senior Director at Teladoc Health, he led initiatives to enhance platform architecture and optimize operations. Previously, as Chief Architect and VP at Seven Bridges Genomics, he was instrumental in developing the company's multi-tenant bioinformatics platform and population analytics products. Mr

Intelligence360
Feb 6th, 2024
3Aware Has Filed A Notice Of An Exempt Offering Of Securities To Raise $8,000,000.00 In New Equity Investment.

3Aware has filed a notice of an exempt offering of securities to raise $8,000,000.00 in New Equity Investment. 3Aware has filed a notice of an exempt offering of securities to raise $8,000,000.00 in New Equity Investment.According to filings with the U.S. Securities and Exchange Commission, 3Aware is raising up to $8,000,000.00 in new funding. Sources indicate that as part of senior management President, Chris Brown played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.About 3Aware3Aware supports immediate access to real-world clinical data for medical device manufacturers in a self-administered platform. MedTech Clinical and Regulatory teams spend exorbitant time and money on the real-world data collection to support keeping devices on the market. With a host of patchwork solutions, there remains no solution to meet their clinical data needs reliably, quickly and affordably

Hit Consultant
Dec 6th, 2023
3Aware Integrates With Mayo Clinic Platform To Streamline Medical Device Compliance

What You Should Know:– 3Aware, a provider of medical device regulatory compliance solutions, and Mayo Clinic Platform, a collaborative ecosystem for healthcare innovators, today announced a new partnership that will integrate 3Aware’s aiSurveillance solution with Mayo Clinic Platform’s extensive clinical data resources.– This collaboration marks a significant milestone in the industry as it will enable medical device manufacturers to automate post-market clinical follow-up (PMCF) and gain deeper insights into device safety and performance.Enhanced Device Coverage and Automated PMCFThe integration of aiSurveillance with Mayo Clinic Platform will significantly increase the device coverage of 3Aware’s solution, enabling manufacturers to automate PMCF for a broader range of devices. By leveraging Mayo Clinic Platform’s comprehensive, longitudinal real-world data, 3Aware will provide manufacturers with deeper insights into device-specific patient experience and outcomes.Reduced Cost, Time, and Risk of Regulatory Compliance3Aware’s aiSurveillance solution has been shown to reduce the cost, time, and risk of MedTech regulatory compliance. By using active surveillance, manufacturers can achieve PMCF-based compliance at less than 50% of the cost and one-tenth of the time of chart reviews and registries. Additionally, aiSurveillance provides a deeper, patient-level understanding with less bias compared to traditional methods.Access to Extensive Clinical DataMayo Clinic Platform provides unparalleled access to extensive, diverse, and de-identified clinical data, including structured data, such as demographics and diagnoses, and unstructured data, such as medical imaging and clinical notes. This data is continually updated and encompasses more than 3 billion images, 676 million clinical notes, 1.6 billion lab results, 9.7 million pathology reports, and 662 million clinical notes.Data Behind Glass: Secure Access to De-identified DataMayo Clinic Platform’s Data Behind Glass model enables secure access to extensive sets of de-identified data without moving it among the contributing organizations across multiple continents. This unique approach ensures patient privacy while providing manufacturers with the data they need to gain valuable insights into device safety and performance

Newswire
Dec 5th, 2023
3Aware Integrates With Mayo Clinic Platform To Speed The Evolution Of Medtech Compliance

INDIANAPOLIS, December 5, 2023 (Newswire.com). -. 3Aware, a pioneering force in the MedTech sector, is working with Mayo Clinic Platform, a collaborative ecosystem for healthcare innovators. This collaboration marks a significant milestone in the industry, as 3Aware integrates with Mayo Clinic Platform to enhance its arsenal of solutions that are redefining the landscape of regulatory compliance for medical device manufacturers

Newswire
Jun 20th, 2023
3Aware Announces New Aisurveillance Solution To Simplify Post-Market Clinical Follow-Up

INDIANAPOLIS, June 20, 2023 (Newswire.com). -. 3Aware today announced the release of 3Aware aiSurveillance, a new approach to real-time medical device surveillance for post-market clinical follow-up (PMCF). This first-of-its-kind solution enables MedTech manufacturers to achieve PMCF and surveillance compliance at 25% of the cost and 1/10 of the time of current methods.

There are no jobs for 3Aware right now.

Find jobs on Simplify and start your career today

💡
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →